1. Home
  2. BCYC vs RM Comparison

BCYC vs RM Comparison

Compare BCYC & RM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • RM
  • Stock Information
  • Founded
  • BCYC 2009
  • RM 1987
  • Country
  • BCYC United Kingdom
  • RM United States
  • Employees
  • BCYC N/A
  • RM N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • RM Finance: Consumer Services
  • Sector
  • BCYC Health Care
  • RM Finance
  • Exchange
  • BCYC Nasdaq
  • RM Nasdaq
  • Market Cap
  • BCYC 492.1M
  • RM 414.8M
  • IPO Year
  • BCYC 2019
  • RM 2012
  • Fundamental
  • Price
  • BCYC $6.90
  • RM $42.67
  • Analyst Decision
  • BCYC Buy
  • RM Hold
  • Analyst Count
  • BCYC 11
  • RM 2
  • Target Price
  • BCYC $22.91
  • RM $30.00
  • AVG Volume (30 Days)
  • BCYC 233.2K
  • RM 47.5K
  • Earning Date
  • BCYC 10-30-2025
  • RM 11-05-2025
  • Dividend Yield
  • BCYC N/A
  • RM 2.83%
  • EPS Growth
  • BCYC N/A
  • RM 35.30
  • EPS
  • BCYC N/A
  • RM 3.47
  • Revenue
  • BCYC $19,281,000.00
  • RM $591,436,000.00
  • Revenue This Year
  • BCYC N/A
  • RM $16.20
  • Revenue Next Year
  • BCYC $0.27
  • RM $7.43
  • P/E Ratio
  • BCYC N/A
  • RM $12.23
  • Revenue Growth
  • BCYC N/A
  • RM 7.19
  • 52 Week Low
  • BCYC $6.10
  • RM $25.41
  • 52 Week High
  • BCYC $28.67
  • RM $44.71
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 39.17
  • RM 64.38
  • Support Level
  • BCYC $6.84
  • RM $41.11
  • Resistance Level
  • BCYC $7.32
  • RM $43.71
  • Average True Range (ATR)
  • BCYC 0.36
  • RM 1.31
  • MACD
  • BCYC 0.01
  • RM -0.28
  • Stochastic Oscillator
  • BCYC 14.56
  • RM 52.78

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About RM Regional Management Corp.

Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.

Share on Social Networks: